2026 ACGT Investigator Award in Cell and Gene Therapy for Solid Tumor Cancers
Funding Amount
$250,000 - $500,000
Deadline
Deadline not published
Grant Type
Foundation
Deadline history & next window
- Cycle
- Annual
- Tracked since
- April 2026
Source: the cycle recorded on this listing. Confirm dates with the funder.
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Geography
- Located in the United States or Canada
Other requirements
- Salary
- Technical assistance
- Supplies
- Animals
Not eligible / not funded
- Not eligible: Capital equipment (not allowed in final year)
Overview
Focus Areas: Translational cell and gene therapy research specifically in solid tumor cancers
Geographic Scope: Research must be conducted at academic medical centers or research centers located in the United States or Canada
Award Amount: $250,000 to $500,000 over two to three years, inclusive of a maximum of 10% indirect costs
Eligible Use of Funds:
- Salary
- Technical assistance
- Supplies
- Animals
- Capital equipment (not allowed in final year)
- May NOT support staff not directly related to the project (e.g., secretaries, administrative assistants)
Eligibility Requirements
- Applicants must hold an MD, PhD, or equivalent degree
- Must be tenure-track or tenured faculty
- Investigator must be conducting original research as an independent faculty member
- No citizenship restrictions (but research location requirement applies)
- Research must be conducted at academic medical centers or research centers in the United States or Canada
Review Process
- Members of the distinguished Scientific Advisory Council oversee review and recommendation
- All Letters of Intent (LOIs) are assessed by at least two Council members or their approved reviewers
- Applicants whose LOIs are responsive to the RFA and mission are invited to submit full applications
- Full applications reviewed carefully by the Council for final approval recommendations
Contact Information
Mailing List: Join the mailing list to receive updates about upcoming Requests for Applications
Organization: Alliance for Cancer Gene Therapy, Inc., a 501(c)(3) organization
How to Apply
Application Process
Step 1: Letter of Intent (LOI)
- Submit LOI through designated application portal
- LOIs are assessed by Scientific Advisory Council members
- Responsive LOIs will be invited to submit full applications
Step 2: Full Application
Applicants whose LOIs are deemed responsive must submit:
- Biosketch
- Budget (with maximum 10% indirect costs)
- Research plan (10-page maximum)
- Literature citations (4 additional pages allowed, separate from 10-page limit)
- Letter of reference
Step 3: Scientific Review
- Full applications reviewed by Scientific Advisory Council
- Council makes recommendations for final approval
Step 4: Grant Agreement
- Grant funds disbursed following execution of a grant agreement between grantee institution and ACGT
Important Notes
- Institutional Signature Required: Applications must be signed by appropriate institution representative (e.g., Signing Official for Assurances in Grants and Contracts Department and/or Legal Department)
- One Submission Only: Applications may be submitted only once; revisions after deadline not permitted
- Pre-Deadline Changes: If changes necessary before deadline, contact Altum Proposal Central customer service at 1-800-875-2562
- No Post-Deadline Changes: No changes can be made after application deadline
- Literature citations are NOT part of the 10-page research plan limit (additional 4 pages allowed)
What Alliance for Cancer Gene Therapy Inc actually gave
Source: IRS Form 990, 2026
- Grants in 2026
- 7
- Total given
- $2.04M
- Median grant
- $482K
- Range
- $13K–$498K
- By dollars: Pennsylvania 26%, Massachusetts 24%, Connecticut 24%. Top recipient cities: Philadelphia, PA; Boston, MA; New Haven, CT.
- 0% of grants with a stated purpose were for general or operating support.
Example grants
University of Pennsylvania Office of Research Services · Philadelphia, PA
Cancer research
$498K
Massachusetts General Hospital · Boston, MA
Cancer research
$487K
Yale University · New Haven, CT
Cancer research
$485K
Roswell Park Cancer Institute · Buffalo, NY
Cancer research
$482K
St Jude Children's Research Hospital · Memphis, TN
Cancer research
$40K
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Biotech Funding Program
Alliance for Cancer Gene Therapy Inc
Amount
Varies
Deadline
Deadline not published
Brain Cancer Research Investigator Grant
B Cured Inc
Amount
$50,000
Deadline
Expected ~April
Based on past cycles
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $499,999
Deadline
January 7, 2027
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
National Institutes of Health
Amount
Varies
Deadline
January 7, 2028
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $500,000
Deadline
January 7, 2028
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
National Institutes of Health
Amount
Varies
Deadline
January 7, 2027
Ready to apply for 2026 ACGT Investigator Award in Cell and Gene Therapy for Solid Tumor Cancers?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found 2026 ACGT Investigator Award in Cell and Gene Therapy for Solid Tumor Cancers. Now let's win it.